SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia
Author:
Affiliation:
1. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston TX USA
2. Stemline Therapeutics Inc.; New York NY USA
3. University of Texas Southwestern Medical Center; Dallas TX USA
Funder
National Institutes of Health Support Grant
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12978/fullpdf
Reference49 articles.
1. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines;Ailles;Blood,1997
2. The role of interleukin-3 in classical Hodgkin's disease;Aldinucci;Leukemia & Lymphoma,2005
3. Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors;Angstreich;British Journal of Haematology,2005
4. BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia;Bedi;Blood,1993
5. Altered bone and mineral metabolism in patients receiving imatinib mesylate;Berman;The New England Journal of Medicine,2006
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics;International Journal of Molecular Sciences;2022-10-05
2. Blastic plasmacytoid dendritic cell neoplasm ( BPDCN ): A promising future in the era of targeted therapeutics;Cancer;2022-06-21
3. New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy;International Journal of Molecular Sciences;2022-03-31
4. Relapse of tagraxofusp treated blastic plasmacytoid dendritic cell neoplasm with loss of CD123 expression;Journal of Hematopathology;2021-12-02
5. Chronic myeloid leukemia stem cells: targeting therapeutic implications;Stem Cell Research & Therapy;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3